News Roundup: March 13 to March 17
Your weekly roundup of the latest news from Drug Topics®.
Novo Nordisk To Cut Insulin Prices Up To 75%
According to a company press release, the price reductions will go into effect at the start of 2024.
US District Judge Hearing Arguments to Potentially Halt Distribution of Abortion Pill Mifepristone
The decision could potentially limit abortion access for people all around the United States.
FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine As Booster Dose For Young Children
A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19.
FDA Grants De Novo Approval to Non-Invasive Tinnitus Treatment Device
The product, called Lenire, uses bimodal stimulation and will be available in April 2023.
Nasal Spray For Migraines Gets FDA Approval
The spray, called Zavzpret, intends to help individuals who struggle with migraines but can't take oral medication because of nausea or vomiting.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
